Ira Winer, MD, PhD, assistant professor in the the Division of Gynecologic Oncology at Wayne State University, discusses the outlook on immunotherapy in the treatment landscape of gynecologic cancers.
Videos
Relapsed Follicular Lymphoma
Managing Relapsed Follicular Lymphoma
Ursula A. Matulonis, MD, director, Gynecologic Oncology, Dana-Farber Cancer Institute, professor of medicine, Harvard Medical School, discusses initial safety and activity findings from a phase IB escalation study of mirvetuximab soravtansine, a folate receptor alpha-targeting antibody-drug conjugate, with pembrolizumab (Keytruda) in patients with platinum-resistant epithelial ovarian cancer.
Treatment of NSCLC With Uncommon EGFR Mutations
Tanios Bekaii-Saab, MD, professor of medicine at the Mayo Clinic, discusses results of the ReDOS trial. In the trial, investigators compared 2 arms with different dosing strategies for regorafenib in patients with metastatic colorectal cancer.
Treatment of Relapsed Follicular Lymphoma with High Risk Status
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Early Relapse Guides Use of CAR T Vs Other Options in LBCL
2
Real-World Data Link Higher Hemoglobin to Improved Survival in MDS
3
Dr Mayer on Giredestrant's Success in Early Breast Cancer
4
Sacituzumab Govitecan: Elevating Quality of Life in First-Line TNBC
5
